The search for new pharmaceuticals that are specific for diseased rather than normal cells in the case of cancer and viral disease has raised interest in locally acting drugs that act over short distances within the cell and for which different cell compartments have distinct sensitivities. Thus, photosensitizers (PSs) used in anti-cancer therapy should ideally be transported to the most sensitive subcellular compartments in order for their action to be most pronounced. Here we describe the design, production, and characterization of the effects of bacterially expressed modular recombinant transporters for PSs comprising 1) α-melanocyte-stimulating hormone as an internalizable, cell-specific ligand; 2) an optimized nuclear localization sequence of the SV40 large T-antigen; 3) an Escherichia coli hemoglobin-like protein as a carrier; and 4) an endosomolytic amphipathic polypeptide, the translocation domain of diphtheria toxin. These modular transporters delivered PSs into the nuclei, the most vulnerable sites for the action of PSs, of murine melanoma cells, but not non-MSH receptor-overexpressing cells, to result in cytotoxic effects several orders of magnitude greater than those of nonmodified PSs. The modular fusion proteins described here for the first time, capable of cell-specific targeting to particular subcellular compartments to increase drug efficacy, represent new pharmaceuticals with general application.
with a simpler component mediating release from endosomes, such as amphipathic oligopeptides that have already been shown to promote the liberation of macromolecules from the endocytotic pathway compartments (17) . An important aspect is also the technological feasibility of producing the transporting constructs since multicomponent transporters (see above) produced in a laborious and expensive fashion through covalent linkage of different peptide modules via bifunctional cross-linking reagents, even if they prove highly efficient in vivo, are unlikely to find broad clinical application. It is thus expedient to develop recombinant vehicles that would include modules for addressed delivery both to specific target cells and into the most vulnerable compartments thereof.
Here we describe the design, production, and characterization of bacterially expressed modular recombinant transporters (MRTs) for PSs comprising 1) MSH as the internalizable ligand, 2) the optimized T-ag NLS, 3) the Escherichia coli hemoglobin-like protein HMP as a carrier, and 4) an endosomolytic amphipathic peptide. The MRTs delivered the PSs into the nuclei of murine melanoma cells and provided for several orders of magnitude greater cytotoxicity than free PSs. MRTs of the type described here represent new pharmaceuticals with general application in drug delivery.
METHODS

Cell culture
The B16-F1 and M3 mouse melanoma cell lines (American Type Culture Collection, Rockville, MD), both expressing MSH receptors (18, 19) , were used, where the latter displayed less autofluorescence and was thus used for microscopic investigations. Normal mouse embryonic fibroblast cell lines, C3H/10T1/2 and NIH/3T3 (a kind gift of S. L. Kiselev, Institute of Gene Biology, Moscow, Russia), as well as the above melanoma cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum at 37 o C in 5% CO 2 .
Bacteriochlorin p 6 preparation
Bacteriopurpurin p 6 was obtained from Rhodobacter purpuratus by alkaline hydrolysis (20) . The resulting substance was dissolved in dimethyl formamide, where the anhydride ring is opened to give bacteriochlorin p 6. 5'-GTGAGATCTGCGCGTAATGAGCTCCTTGCAAAC-3' (reverse; restriction site underlined, as below -see Fig. 1 for assignment), and plasmid pPR28 (21) as a template.
The MSH module was generated synthetically from the oligonucleotides M1, 5'-GATCCTACTCCATGGAACACTT-3'; M2, 5'-CCGTTGGGGCAAGCCGGTATA-3'; M3, 5'-AGCTTATACCGGCTTGCCC-3' (stop codon complement in bold, as below); and M4, 5'-CAACGGAAGTGTTCCATGGAGTAG-3'.
GALA was produced analogously using G1, 5' -CATGGGATCCTGGGAAGCTGCTC-3;' G2, 5' -TGGCTGAAGCACTGGCAGAGGCAGC-3' ; G3, 5' -GGCCGCTGCCTCTGCCAGTGCT-3'; G4, 5'-TCAGCCAGAGCAGCTTCCCAGGATCC-3'; G5, 5'-GGCCGAACACCTGGCTGAGGCA-3'; G6, 5' -CTTGCAGAGGCTCTCGAGGCTCT-3' ; G7, 5'-GGCTGCAGGTGGGCCCAGATCTA-3'; G8, 5'-AGCTTAGATCTGGGCCCACCT-3'; G9, 5' -GCAGCCAGAGCCTCGAGAGCCTC-3' ; and G10, 5' -TGCAAGTGCCTCAGCCAGGTGTTC-3' .
The HMP module was generated by PCR using Taq polymerase (SibEnzyme, Novosibirsk, Russia), the PCR primers 5'-GCAAAAAAAGGGATCCCATATGCTTGACGCTC-3' (forward) and 5'-CCGGCAACTCTAGATCTCAGCACCTTATGCG-3' (reverse), and with E. coli chromosomal DNA as the template.
The translocation domain of diphtheria toxin together with the natural spacer between the toxin domains (DTox module), residues 198-384 of the whole toxin, was similarly generated by Taq PCR using the primers 5'-GTAGGTGGATCCGGGTCATCCATAAATCTTGATTGG-3' (forward) and 5'-CCCGTCATCCGGAAATGGTTAAGATCTATGCCCCGG-3' (reverse) and plasmid DNA containing the cloned diphtheria toxin gene (kindly provided by Y. V. Vertiev, N. F. Gamaleya Institute of Epidemiology and Microbiology, Moscow, Russia) as a template.
Plasmid construction is detailed in Fig. 1 , A-F.
Expression was carried out in E. coli strain M15 (carrying plasmid pREP4) according to the QIAGEN protocol (22), except for plasmid pR522-encoded protein, which was produced in strain DH5α carrying plasmid pREP4.
The cells were lysed in 10 mM HEPES-NaOH, pH 7.5, 0.1 mM EDTA, 1 mM DTT, 3 mM phenylmethylsulphonyl fluoride, and 10 µg/ml lysozyme (all from Sigma, St. Louis, MO); sonicated (20 kHz); and centrifuged (17,000 rpm, JA-20 Beckman rotor) for 25 min. The supernatant was loaded onto blue Sepharose CL-6B (Pharmacia, Uppsala, Sweden), and proteins were eluted using a 0.7-1.6 M NaCl gradient. Protein purity was assayed with 10% polyacrylamide gel electrophoresis (Fig. 1 , E' and F') according to Laemmli (23) .
Functional activity of MRT modules
MSH activity of MRTs was tested by assaying melanogenesis in B16-F1 cells (18) . Briefly, cells were seeded at a density of 2500/well in 96-well plates. After 24 h, serial dilutions of MSH (ICN, Moscow, Russia) or MRTs were added to the wells for 36 h, the cells were grown for 2 days, and the melanin absorbance was measured at 405 nm. Endosomolytic modules were tested by calcein release from liposomes at pH 3-7 (24) . NLS-containing MRTs were tested for recognition by α/β importins, expressed in bacteria as glutathione-S-transferase fusion proteins, using an ELISA-based binding assay (25) .
Preparation of PS-MRT conjugates
Chlorin e 6 (Porphyrin Products, Logan, UT) and bacteriochlorin p 6 were conjugated (26) with MRTs (2:1 molar ratio) using cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-4-toluene sulfonate and 1,6-diaminohexane (both from Sigma).
Video-intensified and image-ratio microscopy
To visualize the intracellular localization of MRTs (used as MRT-chlorin e 6 or -bacteriochlorin p 6 conjugates), 10 µM 2',7'-dichlorodihydrofluorescein diacetate (Serva, Heidelberg, Germany), an indicator of reactive oxygen species, was added for 10 min to washed M3 mouse melanoma cells incubated for 18 or 24 h with MRT conjugates and then the cells were washed again, illuminated, and examined as previously described (3, 4, 26) . 2',7'-Dichlorofluorescein production was then visualized immediately using a cooled CCD camera (AT200, Photometrics, Tucson, AZ, or SenSys:0400) coupled to an Axioplan microscope (Carl Zeiss, Jena, Germany). Fluorescence image processing (deconvolution, nearest-neighbor deblurring) was performed according to Agard et al. (27) . The pH of the intracellular microenvironment of MRT conjugates at the sites of reactive oxygen species generation was determined by image-ratio videointensified microscopy (28) . In brief, two specimen fluorescence images were obtained by 2',7'-dichlorofluorescein excitation at 496 and 461 nm; the image ratio reflecting the local pH was translated into conventional colors using the PMIS program (Photometrics).
Cytotoxic assays of PS-MRT conjugates
The B16-F1, C3H/10T1/2, and NIH/3T3cells were seeded into 48 (2000 cells/well)-or 96-well (1000 cells/well) plates for 24 h and then incubated for 18 h with PS or PS-MRT conjugates. The cells were washed three times with Hanks' solution, transferred into DMEM with 2 mg/ml bovine serum albumin (Serva, Heidelberg, Germany), illuminated with a slide projector, with filters (730-1000 nm), 75 kJ/m 2 (100% cell survival without PSs or PS-MRTs), and grown under 5% CO 2 . Cell viability was determined in 3-4 days using methylene blue staining according to Finlay et al. (29) .
RESULTS
Design of modular plasmids encoding MRTs of PSs, synthesis, and purification of the MRTs
We designed the gene modules encoding the corresponding polypeptide module according to the scheme: BamHI site -module sequence -BglII site -stop codon -HindIII site. This structure allows every gene module to be placed at any position along the hybrid gene because it is flanked with BamHI and BglII restriction sites with identical sticky ends. All the constructs were assembled through consecutive cloning and the strong T5 bacteriophage promoter used for protein expression in bacteria (see Methods).
As mentioned above, MSH was chosen as the ligand module conferring recognition by specific target cells (melanoma) through binding to melanocortin receptors with subsequent internalization (30) . The peculiarities of MSH dictated its localization at the C terminus of MRTs: only the N terminus of the hormone can be modified without loss of MSH activity/binding to its receptors (31, 32) . The MSH gene was prepared synthetically using codons optimized for expression in E. coli.
The optimized nuclear targeting module had the amino acid sequence Ser-Ser 112 -Asp-Asp-GluAla-Thr-Ala-Asp-Ala-Gln-His-Ala-Ala 124 -Pro-Pro-Lys-Lys 128 -Lys-Arg-Lys-Val-Glu-AspPro 135 , where the numbers refer to the T-ag amino acid sequence, with the NLS (residues 126-132) underlined; Ser 112 is the site of CK2 phosphorylation that enhances T-ag nuclear import, and Thr 124 (replaced with Ala) is the site of phosphorylation by Cdc2 kinase that inhibits nuclear import (21) .
The endosomolytic modules used were either 1) the GALA peptide shown to make pores in membranes at acidic pH (17, 33) , or 2) the amphipathic translocation domain of diphtheria toxin (DTox) also capable at acidic pH of permeating endocytotic membranes even in supramolecular complexes with chimeric polypeptides and DNA (34, 35) . The latter has been widely used, either alone or together with the catalytic domain, as a component of membrane penetrable fusion proteins (36) (37) (38) .
The GALA gene module was composed of two parts: four oligos for the peptide N-proximal part and six oligos for the C-proximal part; codons were optimized for E. coli expression, introducing Gly and Pro into the N-and C-terminal regions. The diphtheria toxin translocation domain encoding sequence was taken together with the adjacent natural spacer between the toxin domains (DTox module).
Thus, we generated plasmids (Fig. 1 ) encoding a number of MRTs, including pR522: HMP-NLS-MSH; pR523: GALA-HMP-NLS-MSH; pR676: DTox-HMP-NLS-MSH.
The extent of MRT expression ranged from 5-8% of total protein for construct pR523 to 20-30% for constructs pR522 and pR676, with solubility 60-70%. Note that the yield of GALA-HMP-NLS-MSH (pR523) was considerably lower than that of the MRT with the other endosomolytic module (DTox-HMP-NLS-MSH, pR676). The MRTs were purified on blue Sepharose, the single-step purification providing 90-95% purity (Fig. 1) .
Functional testing of MRT modules
The purified chimeric MRTs were initially tested to assess whether their individual modules retained their functional activities and were able to contribute to the overall goal of cell-specific nuclear PS delivery.
MSH and its analogs induce melanin synthesis in melanocyte-related cells through activation of melanocortin receptors (39) . Stimulation of melanogenesis in B16-F1 cells by the MRTs showed that they were able to bind with the melanocortin receptors of these cells to evoke a biological response. The concentrations producing a half-maximal effect (EC 50 ) were similar for the two MRTs: 14 nM for HMP-NLS-MSH and 17 nM for DTox-HMP-NLS-MSH, compared to the EC 50 for native MSH of 0.36 nM (Fig. 2A) . Recombinant peptides designed similarly but not containing the MSH module did not induce melanogenesis in B16-F1 cells (Fig. 2A) .
MRTs delivered into cells by receptor-mediated endocytosis are internalized into endosomes, enclosed membranous structures with weakly acidic internal pH, which they must exit in order to be targeted subsequently to their final intracellular destination, in this case the nucleus, mediated through the action of importins in the cytosol. The propensity of a polypeptide to make pores in membranes in an acidic medium can be assessed from its ability to effect leakage of dye-loaded liposomes at different pHs (33) . In experiments with calcein-loaded liposomes, maximal activity of GALA-HMP-NLS-MSH was observed at about pH 3.5-4 ( Fig. 2B) , which is more acidic than in endosomes (40) . Liposome leakage under the action of DTox-HMP-NLS-MSH (Fig. 2B ) was observed in two pH intervals: 3.5-4.5, which was attributable to the HMP because it alone showed maximal activity at pH 3.5-4.5 (Fig. 2B) , and 4.5-6, which is close to the endosomal pH (40) and was attributable to activity of the DTox moiety. This, together with the fact that GALA-HMP-NLS-MSH was more difficult to express in bacteria (see above), encouraged us to concentrate on DTox-HMP-NLS-MSH for the studies below.
Assessment of the recognition of the MRTs by the nuclear transport-mediating importin α/β heterodimer using an ELISA-based assay (25) indicated that the NLS in the context of the MRTs is capable of mediating high affinity interaction with importins (Fig. 2C) ; the apparent dissociation constants (K d ) for importin binding were 1.9 and 2.5 nM for HMP-NLS-MSH and DTox-HMP-NLS-MSH, respectively. By comparison, a control T-ag NLS peptide including the NLS and optimized phosphorylation site (25) showed a K d of 2 nM, whereas an NLS mutated (Thr 128 -substituted) control peptide, or non-NLS-containing MRT such as DTox-HMP (Fig. 2C ), displayed only very low importin binding, precluding accurate estimation of the K d .
Importantly, covalent attachment of PSs did not affect the functional activities of any of the MRT modules (data not shown).
Intracellular localization of MRTs
Analysis of the localization and sites of intracellular photodynamic action of PS-containing DTox-HMP-NLS-MSH and HMP-NLS-MSH in M3 mouse melanoma cells using the permeant dye 2′,7′-dichlorodihydrofluorescein diacetate as an indicator of reactive oxygen species production (4) revealed that the MRTs accumulated in the cells, with the pattern of accumulation depending on the presence of a functional endosomolytic module in their composition. This cell line also expresses melanocortin receptors (19) but possesses less autofluorescence and therefore was used for microscopic investigations. Production of reactive oxygen species due to DTox-HMP-NLS-MSH was detected in the nuclei of 87.5% of cells, whereas that due to HMP-NLS-MSH was present only in the nuclei of 12.2% of cells (P < 0.05); see also the deconvoluted fluorescence micrographs of Fig. 3, A and B. Results for probing the pH of the intracellular environments of the MRTs by image-ratio videointensified microscopy were consistent with the above results. Figure 4 , A and B, displays the pH-microenvironment of the PS-containing MRTs probed by the pH-sensitive dye 2′,7′-dichlorofluorescein produced intracellularily from 2′,7′-dichlorodihydrofluorescein by reactive oxygen species generated by the PS-MRTs upon illumination. Thus, a pH-specific fluorescence (shown in conventional colors in Fig. 4 ) develops at the subcellular sites where PS-MRT and the dye colocalize. The HMP-NLS-MSH conjugate lacking an endosomolytic module was found in acidic regions of the cells (reddish spots in Fig. 4A ; see also Fig. 4C for match of conventional colors and pH values). No such acidic regions were revealed in the vicinity of DTox-HMP-NLS-MSH conjugate localization (Fig. 4B) , which localized in rather less acidic (yellowish) sites, meaning that the MRT and the dye do not colocalize within the acidic (<5.4) sites in the optical section.
Cytotoxic action of PSs delivered by MRTs to the nuclei of mouse melanoma cells
Evaluation of the photocytotoxic effect on mouse B16-F1 melanoma cells, which overexpress MSH receptors, a property of many melanomas (9) (10) (11) (12) , showed that the efficacy of PS is greatly enhanced by its attachment to MRTs (Fig. 5A) . A half-maximal effect of (bacteriochlorin p 6 )-DTox-HMP-NLS-MSH was attained at a concentration (EC 50 = 22 nM), which is lower than that required for free bacteriochlorin p 6 (EC 50 = 4990 nM) by a factor of 230. (Bacteriochlorin p 6 )-DTox-HMP-NLS-MSH conjugate was not photocytotoxic to normal C3H/10T1/2 (Fig. 5A) or NIH/3T3 (data not shown) mouse fibroblast lines, demonstrating cell-specific activity of the MRT through the MSH module. (Bacteriochlorin p 6 )-HMP-NLS-MSH conjugate, lacking the endosomolytic module, was 5.3 times less active than (bacteriochlorin p 6 )-DTox-HMP-NLS-MSH, possessing this module; PS-MRT conjugates lacking NLS module showed less photocytotoxic activity than the above two conjugates. Free MRTs, not carrying PSs, did not affect viability of B16-F1 melanoma cells (Fig. 5B) .
DISCUSSION
Site-specific drug-delivery systems are one of the most promising approaches in the drug delivery field including anti-cancer therapy (41) (42) (43) . This approach will permit delivery of very specifically acting compounds including proteins and nucleic acids to particular sites of target cells. The physical properties of these compounds, e.g., high molecular mass (>500 Da) or inappropriate solubility, etc., are the main obstacles precluding their application. These compounds may be called "locally acting" drugs because they must be transported into specific intracellular compartments in order to exert their effects. The list of locally acting drugs also includes low-molecular weight drugs such as PSs that act over very short distances comparable with the dimensions of the cell compartments, where the sensitivities of distinct cell compartments to the action of these drugs are different. Such drugs accordingly need to be transported to the most sensitive/vulnerable site of the target cell. To circumvent this transportation problem, several approaches have been developed including the use of 1) antibodies (44) , in some cases able to be internalized (45); 2) ligands to internalizable receptors (46) ; and 3) protein transduction domains (47) . The latter do not confer cell-specific delivery, which is desirable for anti-cancer and other therapies; in contrast, the first two afford cellspecific delivery and uptake but do not provide for transportation to particular intracellular targets.
We think that a combination/modification of the aforementioned approaches as well as inclusion of intracellular targeting signals into the future delivery constructs allows the problem of cellspecific intracellular targeted drug delivery to be overcome. The recombinant transporters of the type described in our present paper fulfil the above requirements and thus represent, we believe, novel, new types of pharmaceuticals with wide application in drug delivery.
The results obtained show that it is possible to design modular chimeric genes encoding MRTs and to obtain these MRTs as 90-95% pure polypeptides after a simple purification procedure. The arrangement of the ligand, carrier, endosomolytic, and NLS modules within the MRTs is governed mainly by the possible dependence of their activity on their position within the whole polypeptide.
The modules of the chimeric MRTs retain their functional activities so that they are able to interact with the corresponding internalizable receptors overexpressed on target cells (e.g., mouse melanoma), escape from acidic compartments such as endosomes after internalization, be transported into the cell nucleus, and also carry PSs. These data taken together clearly indicate that NLS-mediated nuclear localization of PSs enhances their activities, again confirming that the nucleus is a hypersensitive site for photodynamic damage (1, 3, 4, 48, 49) . The cytotoxic activity of the MRT-linked PSs exceeded free PSs by several orders of magnitude. It is not clear at this stage whether the DTox-HMP-NLS-MSH conjugates detected in the nuclei of melanoma cells on the basis of PS-generated fluorescence are fully intact, but since nuclear fluorescence is observed (Figs. 3 and 4) , it is clear that PSs have been delivered into the nuclei by the MRT. These results are indicative of the prospects of using recombinant chimeric multicomponent vehicles for these and, possibly, for other locally acting drugs such as alpha-particle emitting radionuclides where the dose of radioactivity necessary to kill 63% of cells (D 0 ), of 211-astatine, delivered to human hepatoma cell nuclei by our modular transporters, is one order of magnitude less than that of free 211 At -(unpublished observations).
MRTs of the type described here, capable of cell-specific targeting to particular subcellular compartments to increase drug efficacy, represent new pharmaceuticals with potential general application. The different modules of the MRTs, which are highly expressed and easily purified to retain full activity of each of the modules, are, of course, interchangeable, meaning that they can be tailored for particular applications, e.g., targeting signals for lysosomal, membrane, or mitochondrial location can substitute the NLS in the case of drugs with optimal activity in these compartments. Similarly, ligands other than MSH can be used depending on the desired target cell type, e.g., an MRT containing epidermal growth factor as a ligand and conjugated with bacteriochlorin p 6 showed higher photocytotoxic efficacy than free bacteriochlorin p 6 by a factor of 900 (human A431 epidermoid carcinoma cells) (unpublished observations). The HMP moiety can also be substituted by domains binding other types of drugs/molecules with high affinity; an example of this is the use of DNA-binding domains for DNA delivery in gene therapy (50) . Our modular/combinatorial approach to drug delivery based on MRTs, we believe, thus constitutes the first step toward developing a new generation of pharmaceuticals. 
